EPISODE · Jan 27, 2023 · 20 MIN
Nivolumab in MGMT methylated GBM
from Neuro-Oncology: The Podcast · host Dr. Jasmin Jo, Dr. Michael Lim, Dr. Iyad Alnahhas
Description: Dr. Jasmin Jo interviews Dr. Michael Lim about his and his team's recent manuscript entitled: "Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter", published online in Neuro-Oncology in November 2022.
NOW PLAYING
Nivolumab in MGMT methylated GBM
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m